Cargando…

A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease

Neurodegenerative diseases are characterized by adverse cellular environments and pathological alterations causing neurodegeneration in distinct brain regions. This development is triggered or facilitated by conditions such as hypoxia, ischemia or inflammation and is associated with disruptions of f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burtscher, Johannes, Maglione, Vittorio, Di Pardo, Alba, Millet, Grégoire P., Schwarzer, Christoph, Zangrandi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826574/ https://www.ncbi.nlm.nih.gov/pubmed/33430140 http://dx.doi.org/10.3390/ijms22020582

Ejemplares similares

Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
por: Burtscher, Johannes, et al.
Publicado: (2020)

Brain Region and Cell Compartment Dependent Regulation of Electron Transport System Components in Huntington’s Disease Model Mice
por: Burtscher, Johannes, et al.
Publicado: (2021)

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models
por: Di Pardo, Alba, et al.
Publicado: (2016)

Tractography of the Corpus Callosum in Huntington’s Disease
por: Phillips, Owen, et al.
Publicado: (2013)

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014)

The G‐protein biased partial κ opioid receptor agonist 6′‐GNTI blocks hippocampal paroxysmal discharges without inducing aversion
por: Zangrandi, Luca, et al.
Publicado: (2016)

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Proenkephalin Derived Peptides Are Involved in the Modulation of Mitochondrial Respiratory Control During Epileptogenesis
por: Burtscher, Johannes, et al.
Publicado: (2018)

De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Activation of kappa opioid receptors reduces EEG seizure activity in a mouse model of temporal lobe epilepsy
por: Zangrandi, Luca, et al.
Publicado: (2011)

Activation of kappa opioid receptors reduces seizure activity in a dose-dependent way
por: Zangrandi, Luca, et al.
Publicado: (2012)

Sprouty2 and ‐4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damage
por: Thongrong, Sitthisak, et al.
Publicado: (2015)

Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model
por: Di Pardo, Alba, et al.
Publicado: (2019)

Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease
por: Di Pardo, Alba, et al.
Publicado: (2013)

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
por: Di Pardo, Alba, et al.
Publicado: (2018)

DNA instability in replicating Huntington's disease lymphoblasts
por: Cannella, Milena, et al.
Publicado: (2009)

Caution is needed on the effect of altitude on the pathogenesis of SAR-CoV-2 virus()
por: Burtscher, Johannes, et al.
Publicado: (2020)

The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic
por: Burtscher, Johannes, et al.
Publicado: (2021)

Response to: The mitochondria-targeted antioxidant MitoQ attenuates exercise-induced mitochondrial DNA damage (Williamson et al., available online 6 August 2020, 101,673)
por: Burtscher, Johannes, et al.
Publicado: (2020)

Does living at moderate altitudes in Austria affect mortality rates of various causes? An ecological study
por: Burtscher, Johannes, et al.
Publicado: (2021)

The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential
por: Burtscher, Johannes, et al.
Publicado: (2017)

Differences in the prevalence of physical activity and cardiovascular risk factors between people living at low (<1,001 m) compared to moderate (1,001–2,000 m) altitude
por: Burtscher, Martin, et al.
Publicado: (2021)

The Impact of Training on the Loss of Cardiorespiratory Fitness in Aging Masters Endurance Athletes
por: Burtscher, Johannes, et al.
Publicado: (2022)

Health Benefits of Residence at Moderate Altitude Do Not Reduce COVID-19 Mortality
por: Burtscher, Johannes, et al.
Publicado: (2022)

Hypoxia and the Aging Cardiovascular System
por: Raberin, Antoine, et al.
Publicado: (2023)

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington’s Disease
por: Waters, Susanna, et al.
Publicado: (2018)

Hypoxic exercise as an effective nonpharmacological therapeutic intervention
por: Brocherie, Franck, et al.
Publicado: (2020)

Advancing hypoxic training in team sports: from intermittent hypoxic training to repeated sprint training in hypoxia
por: Faiss, Raphaël, et al.
Publicado: (2013)

Preterm birth: Potential risk factor for greater COVID-19 severity?
por: Debevec, Tadej, et al.
Publicado: (2020)

Olympic Sports Science—Bibliometric Analysis of All Summer and Winter Olympic Sports Research
por: Millet, Grégoire P., et al.
Publicado: (2021)

Altitude and COVID‐19: Friend or foe? A narrative review
por: Millet, Grégoire P., et al.
Publicado: (2020)

Exercise–microbiota interactions in aging‐related sarcopenia
por: Burtscher, Johannes, et al.
Publicado: (2022)

Does Regular Physical Activity Mitigate the Age-Associated Decline in Pulmonary Function?
por: Burtscher, Johannes, et al.
Publicado: (2022)

Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2018)

The Muscle-Brain Axis and Neurodegenerative Diseases: The Key Role of Mitochondria in Exercise-Induced Neuroprotection
por: Burtscher, Johannes, et al.
Publicado: (2021)

Impact of High Altitude on Cardiovascular Health: Current Perspectives
por: Mallet, Robert T, et al.
Publicado: (2021)

How much resistance exercise is beneficial for healthy aging and longevity?
por: Burtscher, Johannes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jnjnqv95tl6r9vl24643b6qo50